Alembic Pharma reports Q1 FY27 financial results
Alembic Pharma reports Q1 FY27 financial results. The company released its unaudited financials for the quarter ended June 30, 2026. Key numbers include revenue of ₹427 crore and net profit of ₹28 crore. Performance reflects steady growth in domestic and international markets.
📊 STOCKS: $APL | 🏢 SECTOR: Pharma | #HIGHIMPACT #Earnings
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.